Corrigendum to "Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures" [Bioorg. Med. Chem. 23 (2015) 1601-1612]

Affiliations

¹ Sidney Kimmel Comprehensive Cancer Center, John Hopkins University, Baltimore, MD 21231, United States.
² Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, 70 President St., Charleston, SC 29425, United States.
³ Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy, Wayne State University, 259 Mack Avenue, Detroit, MI 48202, United States.
⁴ Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, 70 President St., Charleston, SC 29425, United States. Electronic address: woster@musc.edu.

Published Erratum

Shannon L Nowotarski et al. Bioorg Med Chem. 2018.

. 2018 Jul 23;26(12):3728-3729.

doi: 10.1016/j.bmc.2018.05.032. Epub 2018 May 30.

¹ Sidney Kimmel Comprehensive Cancer Center, John Hopkins University, Baltimore, MD 21231, United States.
² Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, 70 President St., Charleston, SC 29425, United States.
³ Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy, Wayne State University, 259 Mack Avenue, Detroit, MI 48202, United States.
⁴ Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina, 70 President St., Charleston, SC 29425, United States. Electronic address: woster@musc.edu.

No abstract available

Erratum for

Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures.
Nowotarski SL, Pachaiyappan B, Holshouser SL, Kutz CJ, Li Y, Huang Y, Sharma SK, Casero RA Jr, Woster PM. Nowotarski SL, et al. Bioorg Med Chem. 2015 Apr 1;23(7):1601-12. doi: 10.1016/j.bmc.2015.01.049. Epub 2015 Feb 7. Bioorg Med Chem. 2015. PMID: 25725609 Free PMC article.